Investigations on clinico-chemical correlations in uraemic polyneuritis.
作者信息
Man N K, Cueuille G, Zingraff J, Drueke T, Jungers P, Sausse A, Billon J P, Funck-Brentano J L
出版信息
Proc Eur Dial Transplant Assoc. 1975;11:214-21.
PMID:1197256
Abstract
摘要
相似文献
1
Investigations on clinico-chemical correlations in uraemic polyneuritis.
Proc Eur Dial Transplant Assoc. 1975;11:214-21.
2
A defense of the middle molecule hypothesis.对中分子假说的辩护。
Kidney Int Suppl. 1978 Jun(8):S31-5.
3
Middle molecules in uraemia.尿毒症中的中分子物质。
Proc Eur Dial Transplant Assoc. 1975;11:417-26.
4
Effect of more porous dialysis membranes on neuropathic toxins.多孔性更高的透析膜对神经性毒素的影响。
Kidney Int Suppl. 1975 Jan(2):52-7.
5
6
[Study of toxic activity of blood in uremia].[尿毒症血液毒性活性的研究]
Ter Arkh. 1980;52(4):62-4.
7
Serum middle molecules in uremia.尿毒症患者的血清中分子物质
Artif Organs. 1981;4 Suppl:143-50.
8
Uremic middle molecules exist and are biologically active.尿毒症中间分子确实存在且具有生物活性。
Clin Nephrol. 1979 May;11(5):229-38.
9
Toxicity of uremia: physiopathology and clinical signs.尿毒症的毒性：生理病理学与临床体征。
Contrib Nephrol. 1989;71:1-9.
10
Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.尿毒症患者血浆超滤物中中分子物质的色谱分析
Nephrol Dial Transplant. 1993;8(2):188.
引用本文的文献
1
Mechanisms underlying performance impairments following prolonged static stretching without a comprehensive warm-up.长时间静态拉伸且无全面热身情况下运动表现受损的潜在机制。
Eur J Appl Physiol. 2021 Jan;121(1):67-94. doi: 10.1007/s00421-020-04538-8. Epub 2020 Nov 11.
2
Peritoneal dialysability of "uraemic substances".“尿毒症物质”的腹膜透析性
Int Urol Nephrol. 1981;13(2):193-8. doi: 10.1007/BF02082064.
Zotero 插件